Rate of intravenous thrombolysis for acute ischaemic stroke in the North-of-France region and evolution over time

Journal of Neurology

Volumn 261, Issue 7, 2014, Pages 1320-1328

  Dequatre Ponchelle, N ^a,q   Touzani, H ^b   Banh, A ^c   Girard Buttaz, I ^d   Coche, R ^d   Dobbelaere, P ^d   Cordonnier, C ^a,q   Girot, M ^a   Aguettaz, P ^a,q   Mounier Vehier, F ^e   Wiel, E ^a   Bronet, N ^g   Josien, E ^h   Duhamel, P ^h   Mihout, M ^d   Maisonneuve, A ^d   Mackowiak, A ^f   Bodenant, M ^a,q   Williatte, P ^a   Leclerc, X ^a,q   Lefebvre, C ^e   Nigeon, O ^e   Devos, P ⁱ   Duncan, G ⁱ   Malanda, G ^j   Majed, B ^k   Dereeper, O ^l   Pegoraro V ^l   Rosolacci, T ^m   Alarcon, P ^m   Koral, E ^m   Pasquini, M ^f   Verclytte, S ^g   N'Kuendjo, J B ^b   Campagne, J B ^b   Le Coz, P ^k   Devienne, J ^k   Seth, Z ^d   Tholliez, R ^d   Henon H ^a,q   Smith, G ^a   Dumont, F ^c   Agbemebia, F ^c   Behra, J M ^c   Pollet, D ⁿ   Coffin, P ⁿ   Lavau, P ⁿ   Verier A ^d   Lucas, C ^a   Smaiti, N ^a   Dalinval, P ^o   Dallongeville, J ^p   Valette, P ^k,l   Pruvo, J P ^a,q   Goldstein, P ^a   Leys, D ^a,q   more..

^a LILLE UNIVERSITY HOSPITAL   (France)

^b Dunkerque Hospital   (France)

^c Tourcoing Hospital   (France)

^d CENTRE HOSPITALIER DE VALENCIENNES   (France)

^e Lens Hospital   (France)

^f Catholic Institute of Lille Hospital   (France)

^g Catholic Institute of Lille   (France)

^h University Hospital Bethune   (France)

ⁱ Boulogne Hospital   (France)

^j CENTRE HOSPITALIER DE ROUBAIX   (France)

^k Arras Hospital   (France)

^l Department of Neurology   (France)

^m SMUR   (France)

ⁿ Cambrai General Hospital   (France)

^o Public Health Regional Agency   (France)

^p INSTITUT PASTEUR DE LILLE   (France)

^q UNIV LILLE   (France)

more..

Author keywords

Cerebral ischaemia; Ischaemic stroke; Population; rt PA; Stroke; Stroke unit; Thrombolysis

Indexed keywords

ALTEPLASE; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BLOOD CLOT LYSIS; BRAIN ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TELEMEDICINE; ADULT; AGED; COMPLICATION; FRANCE; INTRAVENOUS DRUG ADMINISTRATION; LONGITUDINAL STUDY; MIDDLE AGED; PROCEDURES; RETROSPECTIVE STUDY; STROKE;

ADMINISTRATION, INTRAVENOUS; ADULT; AGED; BRAIN ISCHEMIA; FRANCE; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; RETROSPECTIVE STUDIES; STROKE; TELEMEDICINE; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84905054187     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-014-7344-5     Document Type: Article

References (36)

1. Langhorne P, Williams BO, Gilchrist W, Howie K (1993) Do stroke units save lives? Lancet 342:395-398
2. International-Stroke-Trial-Collaborative-Group (1997) The international stroke trial (IST): a randomised trial if aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet 349:1569-1581
3. CAST-Collaborative-Group (1997) CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. Lancet 349:1641-1649
4. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. New Engl J Med 333:1581-1587
5. Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D (2008) Thrombolysis with alteplase 3 to 4.5 h after acute ischemic stroke. N Engl J Med 359:1317-1329
6. Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, Albers GW, Kaste M, Marler JR, Hamilton SA, Tilley BC, Davis SM, Donnan GA, Hacke W, Allen K, Mau J, Meier D, del Zoppo G, De Silva DA, Butcher KS, Parsons MW, Barber PA, Levi C, Bladin C, Byrnes G (2010) Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 375:1695-1703
7. Vahedi K, Hofmeijer J, Jüttler E, Vicaut E, George B, Algra A, Amelink GJ, Schmiedeck P, Schwab S, Rothwell PM, Bousser MG, van der Worp HB, Hacke W (2007) Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol 6(3):215-222
8. Hill MD, Buchan AM (2005) Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study (CASES). CMAJ 172:1307-1312
9. Bateman BT, Schumacher HC, Boden-Albala B, Berman MF, Mohr JP, Sacco RL, Pile-Spellman J (2006) Factors associated with in-hospital mortality after administration of thrombolysis in acute ischemic stroke patients: an analysis of the nationwide inpatient sample 1999 to 2002. Stroke 37:440-446
10. Wahlgren N, Ahmed N, Davalos A, Ford GA, Grond M, Hacke W, Hennerici MG, Kaste M, Kuelkens S, Larrue V, Lees KR, Roine RO, Soinne L, Toni D, Vanhooren G (2007) Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 369:275-282
11. Wahlgren N, Ahmed N, Davalos A, Hacke W, Millan M, Muir K, Roine RO, Toni D, Lees KR (2008) Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study. Lancet 372:1303-1309
12. Leys D, Ringelstein EB, Kaste M, Hacke W (2007) The main components of stroke unit care: results of a European expert survey. Cerebrovasc Dis 23:344-352
13. Audebert HJ, Moulin T (2009) Telestroke: the use of telemedicine in stroke care. Preface. Cerebrovasc Dis 27(Suppl 4):V-VI
14. Liman TG, Winter B, Waldschmidt C, Zerbe N, Hufnagl P, Audebert HJ, Endres M (2012) Telestroke ambulances in prehospital stroke management: concept and pilot feasibility study. Stroke 43:2086-2090
15. Leys D, Ringelstein EB, Kaste M, Hacke W (2007) Facilities available in European hospitals treating stroke patients. Stroke 38:2985-2991
16. The European Stroke Organisation (ESO) executive committee (2008) Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 25:457-507 (updated at: http://www.eso-stroke.org/pdf/ ESO%420Guidelines-update-Jan-2009.pdf)
17. Bambauer KZ, Johnston SC, Bambauer DE, Zivin JA (2006) Reasons why few patients with acute stroke receive tissue plasminogen activator. Arch Neurol 63:661-664
18. Derex L, Adeleine P, Nighoghossian N, Honnorat J, Trouillas P (2002) Factors influencing early admission in a French stroke unit. Stroke 33:153-159
19. Evenson KR, Foraker RE, Morris DL, Rosamond WD (2009) A comprehensive review of prehospital and in-hospital delay times in acute stroke care. Int J Stroke 4:187-199
20. Casolla B, Bodenant M, Girot M, Cordonnier C, Pruvo JP, Wiel E, Leys D, Goldstein P (2013) Intra-hospital delays in stroke patients treated with rt-PA: impact of preadmission notification. J Neurol 260:635-639
21. Lichtman JH, Watanabe E, Allen NB, Jones SB, Dostal J, Goldstein LB (2009) Hospital arrival time and intravenous t-PA use in US Academic Medical Centers, 2001-2004. Stroke 40:3845-3850
22. Leys D, Cordonnier C, Debette S, Hacke W, Ringelstein EB, Giroud M, Mas JL, Kaste M (2009) Facilities available in French hospitals treating acute stroke patients: comparison with 24 other European countries. J Neurol 256:867-873
23. http://www.insee.fr/2009
24. Bodenant M, Leys D, Debette S, Cordonnier C, Dumont F, Henon H, Girot M, Lucas C, Devos D, Defebvre L, Deplanque D, Leclerc X, Bordet R (2010) Intravenous thrombolysis for acute cerebral ischaemia: comparison of outcomes between patients treated at working versus nonworking hours. Cerebrovasc Dis 30:148-156
25. Cordonnier C, Girot M, Dorp E, Rimetz P, Bouillaguet S, Henon H, Lucas C, Godefroy O, Leys D (2000) Stroke units from scientific evidence to practice: the experience of the Lille stroke unit. Cerebrovasc Dis 10(Suppl 4):17-20
26. Mihout M, Cordonnier C, Girard-Buttaz I, Leys D (2012) Thrombolysis for ischaemic stroke: impact of the extension of the time-window in daily practice. J Neurol Neurosurg Psychiatry 83:227-228
27. Adeoye O, Hornung R, Khatri P, Kleindorfer D (2011) Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years. Stroke 42:1952-1955
28. Fang MC, Cutler DM, Rosen AB (2010) Trends in thrombolytic use for ischemic stroke in the United States. J Hosp Med 5:406-409
29. Nakagawara J, Minematsu K, Okada Y, Tanahashi N, Nagahiro S, Mori E, Shinohara Y, Yamaguchi T (2010) Thrombolysis with 0.6 mg/kg intravenous alteplase for acute ischemic stroke in routine clinical practice: the Japan post-Marketing Alteplase Registration Study (J-MARS). Stroke 41:1984-1989
30. Rudd AG, Hoffman A, Grant R, Campbell JT, Lowe D (2010) Stroke thrombolysis in England, Wales and Northern Ireland: how much do we do and how much do we need? J Neurol Neurosurg Psychiatry 82:14-19
31. Vanacker P, Thijs V, Peeters A, Bruneel B, Laloux P, Druwe P, De Deyn P, Ahmed N, Wahlgren N, Vanhooren G (2012) The Belgian experience with intravenous thrombolysis for acute ischemic stroke. Acta Neurol Belg 110:157-162
32. Leyden JM, Chong WK, Kleinig T, Lee A, Field JB, Jannes J (2011) A population-based study of thrombolysis for acute stroke in South Australia. Med J Aust 194:111-115
33. Kim YS, Park SS, Bae HJ, Cho AH, Cho YJ, Han MK, Heo JH, Kang K, Kim DE, Kim HY, Kim GM, Kwon SU, Kwon HM, Lee BC, Lee KB, Lee SH, Lee SH, Lee YS, Nam HS, Oh MS, Park JM, Rha JH, Yu KH, Yoon BW (2011) Stroke awareness decreases prehospital delay after acute ischemic stroke in Korea. BMC Neurol 11:2
34. Kobayashi A, Czlonkowska A, Ahmed N, Romanowicz S, Glonek M, Nyka WM, Opala G, Wahlgren N (2010) Intravenous recombinant tissue plasminogen activator for acute stroke in Poland: an analysis based on the safe implementation of thrombolysis in stroke (SITS) registry. Acta Neurol Scand 122:229-236
35. Gladstone DJ, Rodan LH, Sahlas DJ, Lee L, Murray BJ, Ween JE, Perry JR, Chenkin J, Morrison LJ, Beck S, Black SE (2009) A citywide prehospital protocol increases access to stroke thrombolysis in Toronto. Stroke 40:3841-3844
36. International-stroke-Trial-Collaborative-Group (2012) The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke [the third international stroke trial (IST-3)]: a randomised controlled trial. Lancet 379(9834):2352-2363